EIKN

EIKON THERAPEUTICS INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

EIKON THERAPEUTICS INC (EIKN) is held as common stock by 5 tracked hedge-fund managers, with a combined reported value of ~$9.70M; the largest are Baker Bros. Advisors, Izzy Englander, Renaissance Technologies. This quarter: 1 new, 2 trimmed. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · MediumThis quarter · Quiet

Common-stock holders5

Congress trades0

Price$7.91vs quarter-end-39.39%

Sectors0

This quarter's moves

New1

Added0

Trimmed / sold2

Top holderBaker Bros. Advisors

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Baker Bros. AdvisorsHold

Value $7.25M0.0% of portfolio555,5552026 Q2

Paul Tudor JonesHold

Value $195.8K0.0% of portfolio15,0002026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Baker Bros. Advisors	2026 Q2	$7.25M	555,555	0.0%	Hold
Paul Tudor Jones	2026 Q2	$195.8K	15,000	0.0%	Hold

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.